Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-171019
Filing Date
2025-08-01
Accepted
2025-08-01 08:21:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d930638d424b3.htm 424B3 270310
2 GRAPHIC g930638g0801041919463.jpg GRAPHIC 3369
  Complete submission text file 0001193125-25-171019.txt   276287
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 251174021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)